NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT05492682 2025-09-05START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Active not recruiting15 enrolled